Outset Medical Series A conversion adds 210.7M shares; total common now 265.5M

Outset Medical, Inc.

On March 7, 2025, issued 19,432 Series A Non-Voting Convertible Preferred shares to directors, officers, and employees after stockholder approval.
On March 10, 2025, 842,753 Series A shares converted into 210,688,250 common shares, raising outstanding common to 265,493,926.
Certificate of Correction filed to fix a scrivener's error in the Series A conversion formula (numerator/denominator swap).
After conversion, 20,587 Series A preferred shares remain outstanding.
Issuance and conversion follow stockholder approval at the March 5, 2025 special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.